474 H. T. Balaydin et al.
4. Kivelä J, Parkkila S, Waheed A, Parkkila AK, Sly WS, Rajaniemi H.
Secretory carbonic anhydrase isoenzyme (CA VI) in human serum.
Clin Chem 1997;43:2318–2322.
27. Sherman W, Day T, Jacobson MP, Friesner RA, Farid R. Novel
procedure for modeling ligand/receptor induced fit effects. J Med
Chem 2006;49:534–553.
5. Karhumaa P, Leinonen J, Parkkila S, Kaunisto K, Tapanainen J,
Rajaniemi H. e identification of secreted carbonic anhydrase
VI as a constitutive glycoprotein of human and rat milk. Proc Natl
Acad Sci USA 2001;98:11604–11608.
28. Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood
JR, Halgren TA et al. Extra precision glide: docking and scoring
incorporating a model of hydrophobic enclosure for protein-
ligand complexes. J Med Chem 2006;49:6177–6196.
6. Supuran CT, Scozzafava A. Carbonic anhydrases as targets for
medicinal chemistry. Bioorg Med Chem 2007;15:4336–4350.
7. Murakami H, Sly WS. Purification and characterization of human
salivary carbonic anhydrase. J Biol Chem 1987;262:1382–1388.
8. Sly WS, Hu PY. Human carbonic anhydrases and carbonic
anhydrase deficiencies. Annu Rev Biochem 1995;64:375–401.
9. Pastorekova S, Parkkila S, Pastorek J, Supuran CT.
Carbonic anhydrases: current state of the art, therapeutic
applications and future prospects. J Enzyme Inhib Med Chem
2004;19:199–229.
10. Ekinci D, Ceyhun SB, Sentürk M, Erdem D, Küfrevioglu OI,
Supuran CT. Characterization and anions inhibition studies of an
a-carbonic anhydrase from the teleost fish Dicentrarchus labrax.
Bioorg Med Chem 2011;19:744–748.
11. Innocenti A, Vullo D, Scozzafava A, Supuran CT. Carbonic
anhydrase inhibitors: interactions of phenols with the 12
catalytically active mammalian isoforms (CA I-XIV). Bioorg Med
Chem Lett 2008;18:1583–1587.
12. Innocenti A, Beyza Oztürk Sarikaya S, Gülçin I, Supuran CT.
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms
I-XIV with a series of natural product polyphenols and phenolic
acids. Bioorg Med Chem 2010;18:2159–2164.
13. Bayram E, Senturk M, Kufrevioglu OI, Supuran CT. In vitro
inhibition of salicylic acid derivatives on human cytosolic
carbonic anhydrase isozymes I and II. Bioorg Med Chem 2008;16:
9101–9105.
14. Gribble GW. Naturally occurring organohalogen compounds-a
survey. J Nat Prod 1992;55:1353–1395.
15. Gribble GW. e diversity of naturally occuring organobromine
compounds. Chem Soc Rev 1999;28:335–346.
29. Nair SK, Ludwig PA, Christianson DW. Two-site binding of phenol in
theactivesiteofhumancarbonicanhydraseII:structuralimplications
for substrate association. J Am Chem Soc 1994;116:3659–3660.
30. Sentürk M, Gülçin I, Dastan A, Küfrevioglu OI, Supuran CT.
Carbonic anhydrase inhibitors. Inhibition of human erythrocyte
isozymes I and II with a series of antioxidant phenols. Bioorg Med
Chem 2009;17:3207–3211.
31. Sentürk M, Gülçin I, Beydemir S, Küfrevioglu OI, Supuran CT.
In Vitro Inhibition of Human Carbonic Anhydrase I and II
Isozymes with Natural Phenolic Compounds. Chem Biol Drug Des
2011;77:494–499.
32. Ceyhun SB, Senturk M, Yerlikaya E, Erdogan O, Kufrevioglu OI,
Ekinci D. Purification and characterization of carbonic anhydrase
from the teleost fish Dicentrarchus labrax (European Seabass) liver
and toxicological effects of metals on enzyme activity, Environ
Toxicol Phar 2010;32:69–74.
33. Laemmli UK. Cleavage of structural proteins during the assembly
of the head of bacteriophage T4. Nature 1970;227:680–685.
34. Parkkila S, Kaunisto K, Rajaniemi L, Kumpulainen T, Jokinen K,
Rajaniemi H. Immunohistochemical localization of carbonic
anhydrase isoenzymes VI, II, and I in human parotid and
submandibular glands. J Histochem Cytochem 1990;38:941–947.
35. Wilbur KM, Anderson NG. Electrometric and colorimetric
determination of carbonic anhydrase. J Biol Chem 1948;176:
147–154.
36. SupuranCT, ScozzafavaA, CasiniA. Carbonicanhydraseinhibitors.
Med Res Rev 2003;23:146–189.
37. Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase
inhibitors and activators and their use in therapy. Expert Opin
er Pat 2006;16:1627–1664.
16. Balaydin HT, Gülçin Í, Menzek A, Göksu S, Sahin E. Synthesis
and antioxidant properties of diphenylmethane derivative
bromophenols including a natural product. J Enzyme Inhib Med
Chem 2010;25:685–695.
17. Sentürk M, Ekinci D, Göksu S, Supuran CT. Effects of dopaminergic
compounds on carbonic anhydrase isozymes I, II, and VI. J Enzyme
Inhib Med Chem (In Press).
38. iry A, Dogné JM, Supuran CT, Masereel B. Carbonic anhydrase
inhibitors as anticonvulsant agents. Curr Top Med Chem
2007;7:855–864.
39. Ekinci D, Sentürk M, Beydemir S, Küfrevioglu OI, Supuran CT. An
alternative purification method for human serum paraoxonase
1 and its interactions with sulfonamides. Chem Biol Drug Des
2010;76:552–558.
18. Talaz O, Gülçin I, Göksu S, Saracoglu N. Antioxidant activity of
5,10-dihydroindeno[1,2-b]indoles containing substituents on
dihydroindeno part. Bioorg Med Chem 2009;17:6583–6589.
19. Akbaba Y, Balaydin HT, Goksu S, Sahin E, Menzek A. Total synthesis
of the biologically active, naturally occurring 3,4-dibromo-5-[2-
bromo-3,4-dihydroxy-6-(methoxymethyl) benzyl]benzene-1,2-
diol and regioselective o-demethylation of aryl methyl ethers. Helv
Chim Acta 2010;93:1127–1135.
20. Balaydin HT, Akbaba Y, Menzek A, Sahin E, Goksu S. First and short
syntheses of biologically active, naturally occurring brominated
mono- and dibenzyl phenols. Arkivoc 2009;XIV:75–87.
21. Pearl IA. Reactions of vanillin and its derived compounds. XXIII.
e synthesis of 4,4′-dihydroxy-3,3′-dimethoxybenzophenone.
J Am Chem Soc 1954;76:3635–3637.
22. Cabaton N, Zalko D, Rathahao E, Canlet C, Delous G, Chagnon
MC et al. Biotransformation of bisphenol F by human and rat liver
subcellular fractions. Toxicol in Vitro 2008;22:1697–1704.
23. Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human
carbonic anhydrases B and C. J Biol Chem 1967;242:4221–4229.
24. Lineweaver H, Burk D. e determination of enzyme dissocation
constants. J Am Chem Soc 1934;56:658–666.
25. Bradford MM. A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-
dye binding. Anal Biochem 1976;72:248–254.
40. Ekinci D, Beydemir S, Küfrevioglu OI. In vitro inhibitory effects of
some heavy metals on human erythrocyte carbonic anhydrases.
J Enzyme Inhib Med Chem 2007;22:745–750.
41. Sentürk M, Talaz O, Ekinci D, Cavdar H, Küfrevioglu OI. In
vitro inhibition of human erythrocyte glutathione reductase
by some new organic nitrates. Bioorg Med Chem Lett
2009;19:3661–3663.
42. Abdülkadir Coban T, Beydemir S, Gülcin I, Gücin I, Ekinci D,
Innocenti A et al. Sildenafil is a strong activator of mammalian
carbonic anhydrase isoforms I-XIV. Bioorg Med Chem
2009;17:5791–5795.
43. Supuran CT. Carbonic anhydrases–an overview. Curr Pharm Des
2008;14:603–614.
44. Ekinci D, Cavdar H, Talaz O, Sentürk M, Supuran CT. NO-releasing
esters show carbonic anhydrase inhibitory action against human
isoforms I and II. Bioorg Med Chem 2010;18:3559–3563.
45. Alp C, Ekinci D, Gültekin MS, Sentürk M, Sahin E, Küfrevioglu OI. A
novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives
and analysis of carbonic anhydrase inhibitory potencies. Bioorg
Med Chem 2010;18:4468–4474.
46. Ceyhun SB, Senturk M, Erdogan O, Kufrevioglu OI. In vitro and
in vivo effects of some pesticides on carbonic anhydrase enzyme
from rainbow trout (Oncorhynchus mykiss) gills. Pestic Biochem
Physiol 2010;97:177–181.
26. Schrodinger Suite, Schrodinger, LLC, New York, USA 2007 (web
47. Nishimori I, Minakuchi T, Onishi S, Vullo D, Scozzafava A, Supuran
CT. Carbonic anhydrase inhibitors. DNA cloning, characterization,
Journal of Enzyme Inhibition and Medicinal Chemistry